Startseite The effect of glucocorticoid replacement therapy on bone mineral density in children with congenital adrenal hyperplasia
Artikel
Lizenziert
Nicht lizenziert Erfordert eine Authentifizierung

The effect of glucocorticoid replacement therapy on bone mineral density in children with congenital adrenal hyperplasia

  • Semra Cetinkaya EMAIL logo und Cengiz Kara
Veröffentlicht/Copyright: 1. Juni 2011
Journal of Pediatric Endocrinology and Metabolism
Aus der Zeitschrift Band 24 Heft 5-6

Abstract

Objectives: 1) To evaluate the effects of glucocorticoid (GC) doses on bone mineral density (BMD) in children with congenital adrenal hyperplasia (CAH), 2) Investigate other factors influencing BMD.

Methods: Twenty-six children with CAH and 11 healthy controls included in the study. All of the patients were examined with dual-energy X-ray absorptiometry (DXA) using a Hologic QDR 1000/W densitometer. The metabolic control state, age at diagnosis GC dose (mg/m2/day), pubertal status, 17 hydroxyprogesterone (17 OHP) levels, bone age (BA), and lumber BMD were evaluated in all cases. BMD (g/cm2), BMD z-score corrected to National Standards (cNS-BMD z-score), BMD z-score corrected to BA (cBABMD), bone mineral content (BMC), BMC corrected to puberty (cPBMC), and bone area (BAR) values were determined. Patients were grouped according to mean on-therapy serum 17 OHP levels as tight control (17 OHP<10 nmol/L) (n:13) and poor control (17 OHP>10 nmol/L) (n:13). All groups were compared with each other.

Results: The age range was 2.1–15.7 years and the mean age (±SD) 9.3 (±3.5) years. There were no significant differences between the groups in terms of GC doses, lumbar BMD values [BMD (g/cm2), BMD z-score corrected to National Standards (cNS-BMD z-score), BMD z-score corrected to BA (cBABMD), bone mineral content (BMC), BMC corrected to puberty (cPBMC), and bone area (BAR)]. However, the BMI value was higher in children with CAH than normal healthy controls. The BA of the poor control, late diagnosed groups and male patients were higher than tight control, early diagnosed group and female patients, respectively. BMC and BA were lower than the control group in tight control with early diagnosed patients. The cBABMD z-score was lower in males with poor control than males with tight control. There were no similar results in female patients.

Conclusions: Although GC treatment seems not to influence BMD in CAH patients in our study, further studies are needed to additionally evaluate daily calcium (Ca) intake, polymorphism of vitamin D receptor, ethnic factors (strict Islamic dress, etc.), socioeconomic status, and 24-h urinary free cortisol level.


Corresponding author: Semra Cetinkaya, 3251. Cadde, 2/28, Yasamkent, Yenimahalle, Ankara 06810, Turkey Phone: +90 505 3884403, Fax: +90 312 3170353

Published Online: 2011-06-01
Published in Print: 2011-06-01

©2011 by Walter de Gruyter Berlin Boston

Artikel in diesem Heft

  1. Publisher's Note
  2. Publisher's Note
  3. Editorial
  4. The damage caused by incomplete and uncontrolled medical information
  5. Images in Pediatric Endocrinology
  6. Dorsolumbar kyphosis: diagnostic value of hook shaped vertebra
  7. Original Contributions
  8. Are adolescent weight-related problems and general well-being essentially an issue of age, gender or rather a pubertal timing issue?
  9. Comparison of methimazole and propylthiouracil in the management of children and adolescents with Graves’ disease: efficacy and adverse reactions during initial treatment and long-term outcome
  10. The effect of glucocorticoid replacement therapy on bone mineral density in children with congenital adrenal hyperplasia
  11. Treatment of symptomatic osteoporosis in children: a comparison of two pamidronate dosage regimens
  12. Stanozolol regulates proliferation of growth plate chondrocytes via activation of ERα in GnRHa-treated adolescent rats
  13. A case of McCune-Albright syndrome associated with pituitary GH adenoma: therapeutic process and autopsy
  14. The role of metabolic syndrome components and adipokines in insulin resistance in prepubertal children
  15. A new heterozygous mutation (D196N) in the Gs alpha gene as a cause for pseudohypoparathyroidism type IA in a boy who had gallstones
  16. Causes and patterns of referral to a tertiary, multidisciplinary program for the treatment of childhood obesity
  17. Vitamin D receptor genotypes are associated with bone mass in patients with Turner syndrome
  18. Plasma leptin and adiponectin concentrations in healthy, non-obese children
  19. Puberty and pubertal growth dynamics in children with idiopathic short stature
  20. Endocrine complications following pediatric bone marrow transplantation
  21. Rare hypertension as a result of 17α-hydroxylase deficiency
  22. Girls with early puberty attain a near-final height similar to their target height
  23. Persistent hyperthyrotropinemia in congenital hypothyroidism: successful combination treatment with levothyroxine and liothyronine
  24. Benign transient hyperphosphatasemia in infants and children: a prospective cohort
  25. The relation between 25-hydroxyvitamin D with peak bone mineral density and body composition in healthy young adults
  26. Childhood obesity: evidence of an association between plasminogen activator inhibitor-1 levels and visceral adiposity
  27. Glargine basal-bolus insulin regimen versus insulin pump therapy: comparison of glycemic control
  28. Patient Report Letters
  29. A new variant of a known mutation in two siblings with permanent neonatal diabetes mellitus
  30. HNF1A mutation presenting with fetal macrosomia and hypoglycemia in childhood prior to onset of overt diabetes
  31. A newborn case with perinatal-lethal Gaucher disease due to R463H homozygosity complicated by C677T homozygosity in the MTHFR gene
  32. Hyperthyroidism presenting with hyperglycemia in an adolescent female
  33. Short Communications
  34. A single base-pair deletion in the WFS1 gene causes Wolfram syndrome
  35. Growth suppression caused by corticosteroid eye drops
  36. Familial glucocorticoid deficiency due to compound heterozygosity of two novel MC2R mutations
  37. Letter to the Editor
  38. Meetings
  39. Meetings Calendar
Heruntergeladen am 7.11.2025 von https://www.degruyterbrill.com/document/doi/10.1515/jpem.2011.189/html
Button zum nach oben scrollen